Manali Petrochemicals Limited Resumes Plant-1 Operations Following Propylene Allocation
Manali Petrochemicals Limited (MPL) has commenced the process of restarting operations at its Plant-1 facility in Manali, Chennai. The restart follows a crucial development involving the allocation of propylene by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.Previously, operations at Plant-1, Manali, Chennai, had been temporarily suspended effective March 12, 2026. The suspension was necessitated by the complete cessation of propylene supply from Chennai Petroleum Corporation Limited (CPCL), which was executed following a directive from the Ministry of Petroleum and Natural Gas (MoPNG).
The operational uncertainty was resolved with the issuance of a Revised Office Memorandum (No. 31026/5/2026-Policy) by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, dated April 17, 2026. This memorandum allocated a fixed daily quantity of propylene to Manali Petrochemicals Limited. This supply, sourced from CPCL, is designated to meet the requirements of the Pharma Industry.
In light of the confirmed propylene allocation and the expected resumption of feedstock supply, MPL began the restart process at Plant-1, Manali, Chennai, beginning on April 20, 2026.
MPL noted that operations at Plant-1 are expected to resume in a phased manner, contingent upon the continued receipt of propylene supplies from CPCL. The Force Majeure condition that previously suspended the plant’s operations is considered resolved to the extent of the propylene allocation provided by the Government of India.
Meanwhile, the operational status of Plant-2 remains unchanged, maintaining the status quo as per previous communications.
MANALIPETC Stock Price Movement
Shares of Manali Petrochemicals Limited are edging higher to ₹55.19 as of 12:56 PM today, gaining 0.04% in live trading. The equity is showing strong momentum, evidenced by a trading volume of 162,269 shares so far in the session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.